| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Netupitant/palonosetron |
| Brand | Akynzeo® |
| Indication | For the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cisplatin-based cancer chemotherapy and for prevention of acute and delayed nausea and vomiting associated with moderately emetogenic cancer chemotherapy. |
| Assessment Process | |
| Rapid review commissioned | 26/08/2015 |
| Rapid review completed | 13/10/2015 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended |
